Increased plasma levels of non-sugar sweeteners in patients with symptomatic carotid atherosclerosis

Kristine Støa Institute of Clinical Medicine, University of Oslo, Norway;b Department of Neurology, Oslo University Hospital, NorwayCorrespondence[email protected]
View further author information

Karolina R. Skagenb Department of Neurology, Oslo University Hospital, NorwayView further author information

Jørgen Valeurc Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, Oslo, NorwayView further author information

Kuan Yanga Institute of Clinical Medicine, University of Oslo, Norway;d Research Institute of Internal Medicine, Oslo University Hospital, NorwayView further author information

Vigdis Bjerkelia Institute of Clinical Medicine, University of Oslo, NorwayView further author information

Pål Aukrusta Institute of Clinical Medicine, University of Oslo, Norway;d Research Institute of Internal Medicine, Oslo University Hospital, Norway;e Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, NorwayView further author information

Mona Skjellanda Institute of Clinical Medicine, University of Oslo, Norway;b Department of Neurology, Oslo University Hospital, NorwayView further author information

Bente Halvorsena Institute of Clinical Medicine, University of Oslo, Norway;d Research Institute of Internal Medicine, Oslo University Hospital, NorwayView further author information

show all

Increased plasma levels of non-sugar sweeteners in patients with symptomatic carotid atherosclerosis

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Increased plasma levels of non-sugar sweeteners in patients with symptomatic carotid atherosclerosis

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date